openFDA 药品召回·· 7 天前精选AI 评分58
费森尤斯医疗召回含1.5%葡萄糖的DELFLEX腹膜透析液
DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,000 mL - Single Dose Bag, Sterile and Non-Pyrogenic, Rx only, CAT.NO. 054-20221. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-206-92
AI 导读
openFDA 药品召回信息显示,费森尤斯医疗(Fresenius Medical Care)Renal Therapies Group 召回含1.5%葡萄糖、低镁低钙的 DELFLEX 腹膜透析液(2000 mL 单剂量袋,NDC 46163-206-92)。召回原因为无菌性无法保证,已收到受影响批次主袋印刷区微小穿孔可能导致渗漏的投诉。
推荐理由
召回原因指向主袋印刷区微孔渗漏导致无菌性无法保证,可了解该批腹膜透析液的缺陷环节。
来源:openFDA 药品召回 · api.fda.gov